Biotech · Private company
Samus Therapeutics, Inc.
Track this companyFree. Adds Samus Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- Blood BiomarkersPhase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Cerebrospinal fluid (CSF) BiomarkersPhase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Fluorodeoxyglucose (FDG) Positron emission tomography (PET)Phase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- PU-ADPhase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Rating ScalesPhase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Tau Positron emission tomography (PET)Phase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Blood DrawsPhase 1 · LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- IcapamespibPhase 1 · Recurrent Glioblastoma Multiforme (GBM)ClinicalTrials.gov · fetched Nov 12, 2026
- PET ScanPhase 1 · LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- PU-ADPhase 1 · LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- PU-ADPhase 1 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- PU-H71Phase 1 · MyelofibrosisClinicalTrials.gov · fetched Nov 12, 2026
- PU-H71Phase 1 · Primary Myelofibrosis (PMF)ClinicalTrials.gov · fetched Nov 12, 2026
- RuxolitinibPhase 1 · MyelofibrosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant GliomaPHASE1 · TERMINATED · started Dec 27, 2021ClinicalTrials.gov NCT04782609 · fetched Nov 12, 2026
- To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD DementiaPHASE2 · TERMINATED · started Jun 30, 2020ClinicalTrials.gov NCT04311515 · fetched Nov 12, 2026
- Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking RuxolitinibPHASE1 · TERMINATED · started Aug 12, 2019ClinicalTrials.gov NCT03935555 · fetched Nov 12, 2026
- A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy SubjectsPHASE1 · TERMINATED · started Jun 24, 2019ClinicalTrials.gov NCT03935568 · fetched Nov 12, 2026
- Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of MyelofibrosisPHASE1 · TERMINATED · started May 24, 2018ClinicalTrials.gov NCT03373877 · fetched Nov 12, 2026
- PET Imaging of Subjects Using 124I-PU-ADEARLY_PHASE1 · TERMINATED · started Apr 1, 2016ClinicalTrials.gov NCT03371420 · fetched Nov 12, 2026